Latest Germany News

Talga Group has entered a strategic development agreement with German battery innovator V4Smart to co-develop high-performance graphite anodes for fast-charging lithium-ion batteries, aiming for commercial readiness by 2027.

Zelira Therapeutics has raised nearly US$33 million from ThirdGate Capital to advance its HOPE® 1 drug targeting autism-related Phelan-McDermid Syndrome through FDA clinical trials. This funding milestone sets the stage for pivotal regulatory progress in the US.

ECS Botanics reports a $218k positive operating cash flow in Q2 FY26, driven by strong B2C growth and new product launches. The company also secured $1.95 million in funding to fuel European expansion and product development.

Nova Eye Medical has reported a record US$6.1 million in sales for the December 2025 quarter, driven by strong US demand and a 24% annual growth rate that outpaces the industry.

Kalamazoo Resources has initiated a $2 million underwritten Share Purchase Plan, offering eligible shareholders shares at a 16.4% discount to recent prices. The offer aims to fund exploration and development activities across its Victorian and Western Australian projects.

Altech Batteries has won conditional approval for a €46.11 million German government grant to support its innovative CERENERGY Sodium-Chloride Solid-State battery project, advancing plans for a 120 MWh manufacturing facility in Saxony.

Terrain Minerals has made significant progress across its gold, lithium, and rare earth projects during the December 2025 quarter, including drilling milestones and a successful $2.76 million capital raise. The company targets a maiden resource at its Lightning gold prospect by mid-2026.

Sprintex Limited has landed its largest-ever €15.6 million order for ZLD-UP® manure processing systems, marking a pivotal shift from evaluation to commercial deployment across Europe. This multi-year contract sets the stage for substantial revenue growth and a path to profitability in FY26.

Vulcan Energy Resources has successfully closed its retail entitlement offer, raising €147 million and increasing HOCHTIEF's ownership to over 15%, eliminating the need for a conditional placement.

Imricor Medical Systems has secured Charité University Hospital in Berlin as the second global site for its VISABL-VT clinical trial, marking a significant milestone in real-time MRI-guided cardiac ablation technology.

Altech Batteries has abruptly ended its partnership with AMPower, shifting focus to its own advanced battery technologies as part of a strategic reset by its new board.

Epsilon Healthcare Limited has unveiled a comprehensive pre-reinstatement disclosure, highlighting improved financial health and a strategic growth plan focused on operational stability and expansion.